TrumpRx Explained: Why Markets are Watching This New Pharma Website
President Donald Trump this week launched TrumpRx, a government-backed platform geared toward decreasing prescription drug costs for Americans paying out of pocket. While the announcement initially raised considerations about pricing stress, monetary markets have delivered a transparent response. Major pharmaceutical shares rallied on February 6, signaling that buyers don’t see TrumpRx as a near-term risk…
